News

Rani Therapeutics Announces Participation in Notable Conference

Rani Therapeutics Announces Participation in Notable Conference

Rani Therapeutics to Join Evercore Healthcare Conference

Rani Therapeutics Holdings, Inc. (Nasdaq: RANI), based in San Jose, is excited to announce its participation in the Evercore Healthcare Conference where its management will share insights into their innovative approaches in the biotherapeutics realm. This esteemed event will feature the company’s leaders engaging in a discussion designed for investors and industry enthusiasts alike.

Event Details

The 8th Annual Evercore Healthcare Conference is scheduled for Wednesday, December 3 at 8:45 am E.T. The setting will foster an interactive experience, as Chief Executive Officer Talat Imran and Chief Financial Officer Svai Sanford lead a fireside chat, complemented by personalized 1x1 meetings. This format promotes a unique opportunity for stakeholders to delve deeper into Rani’s strategic initiatives.

Understanding Rani Therapeutics

Rani Therapeutics stands at the forefront of biotherapeutic innovation, concentrating on technologies that facilitate the oral delivery of biologics and medications. Their proprietary RaniPill capsule exemplifies this commitment, designed specifically to replace traditional methods of administering drugs—such as injections—with more convenient oral dosing. This groundbreaking approach not only enhances patient comfort but also has the potential to improve compliance and outcomes.

Innovative Technology

At the core of Rani’s mission is the RaniPill capsule, a patented platform that transforms how biologics are delivered. By conducting a series of rigorous preclinical and clinical trials, Rani Therapeutics has successfully demonstrated the safety and bioavailability of its oral dosage forms. The ongoing advancements in this technology could revolutionize treatment modalities for various conditions, making it a topic of great interest at healthcare forums like the Evercore Conference.

Engaging with Stakeholders

For those interested in this conference, Rani Therapeutics invites you to access the live webcast through their Investor Relations section on their website. The replay will be available following the session, allowing interested individuals to absorb the insights shared during the presentation.

Contact for Investors and Media

Communication remains a priority for Rani Therapeutics. Investors or members of the media seeking further information can reach out via the company's dedicated email contacts. For investors, the address is investors@ranitherapeutics.com. For media inquiries, they can connect at media@ranitherapeutics.com.

Frequently Asked Questions

What is the purpose of Rani Therapeutics' participation in the conference?

The participation showcases Rani's innovative technologies in oral delivery of biologics and engages with investors and industry experts.

Who will be presenting at the conference?

CEO Talat Imran and CFO Svai Sanford will represent Rani Therapeutics during the event.

What technology does Rani Therapeutics focus on?

Rani Therapeutics specializes in oral administration technologies for biologics, particularly through their proprietary RaniPill capsule.

How can interested parties access the conference?

The conference webcast can be accessed from the Investor Relations section on Rani's website.

How can I get in touch with Rani Therapeutics?

Investors can reach the company at investors@ranitherapeutics.com and media inquiries can be sent to media@ranitherapeutics.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Envision and Tsinghua Propel Climate Innovation at COP31

Updated Category News Views 87

Collaborating for a Greener Future On the bustling stage of COP31 in Antalya, Turkey, Envision Energy and Tsinghua University teamed up with the Global Alliance of Universities on Climate (GAUC) to showcase a bold agenda. Their focus transcends mere dialogue, pushing for actionable climate solutions anchored in technological innovation, academic synergy, and the dynamism...

Continue Reading
A Teen's Opera Encounter Inspires Decades of Passion

Updated Category News Views 0

Unraveling a Lifelong Opera Obsession Back in the dog-eared days of 1970, a teenager waltzed into the Metropolitan Opera and stumbled onto a passion that'd pulse alongside him for over half a century. Now, David E. Lapin rolls out his personal chronicle, 'A Sound Obsession: Fifty-Five Years of Opera at the Met.' Folks, we’re diving into a cultural tapestry that’s...

Continue Reading
Jones Soda Expands into Nutrition with UCAN Deal

Updated Category News Views 145

Well, Jones Soda Co. (CSE: JSDA) is stirring the pot with its recent move to acquire the UCAN functional nutrition assets. Popped the news on November 12, 2026, and it turns out they've shelled out a cool $700,000 in cash and taken on $500,000 in liabilities for the privilege. This isn't some casual shuffle of dollars and cents—this one's a strategic gambit aimed at...

Continue Reading
Ampace Focuses on Battery Safety Standards at RE+ 2026

Updated Category News Views 146

Battery Safety Takes Center Stage No mystery here: the safety of our beloved lithium-ion batteries is crucial, especially as AI data centers sprout like weeds. At RE+ 2026, Ampace is putting its chips on the table by spotlighting this hot topic. Dr. Drew Feng, their Chief Safety Officer, is set to reveal the big guns: findings from the PU100 large-scale fire test. Mark...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 279

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Daqo New Energy Faces Key Investor Meeting in December

Updated Category News Views 88

Spotlight on December's Agenda for Daqo Shareholders Who'd have thought we'd be looking at another year end with the same burning energy interests? Daqo New Energy Corp. (NYSE: DQ) is setting up for its annual general meeting (AGM) dated December 10, 2026. Mark your calendars, because these gatherings can be more than just straightforward affairs; sometimes they reveal...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 86

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Bacterial Breakthrough in Cancer Therapy: Game Changer?

Updated Category News Views 7

Blurring Lines Between Bugs and Biotech Well, wouldn't you know it, the eggheads over at Jeonbuk National University in South Korea are at it again, pushing the boundaries of what these little bacterial buggers can do. This time, they’ve had a crack at cancer therapy, using engineered Salmonella to pack a double punch against breast cancer in mice. Now, if that ain't...

Continue Reading
SwitchBot's Hub 4: A Step Toward a Connected Future

Updated Category News Views 37

Turning a House Into a Smart Home Haven Out of Tokyo and onto the world stage, SwitchBot's got something new cooking that might just shake up the smart home scene. They've launched the Hub 4, a gadget that's like the Swiss Army knife of home control. For those who like things simple, this is a one-hub-to-rule-them-all kind of deal. 101,000 Reasons to Notice Now, they...

Continue Reading
Nord Anglia Schools Shine with 13 Tes Awards Nominations

Updated Category News Views 87

Nord Anglia's Moment of Glory at Tes Awards You think you know the big players in the educational game? Well, guess again. Nord Anglia's come out swinging with a whopping 13 finalist nominations at the 2026 Tes Awards for International Schools. It ain't easy making waves in the education sector, but these folks are showing they've got what it takes to turn heads, not just...

Continue Reading

Top 5 Most Recently Viewed Articles

Conrad Industries Reports Strong Third Quarter Financial Growth

Updated Category News Views 393

Conrad Industries Announces Third Quarter 2024 Financial Results Conrad Industries, Inc. (OTC Pink: CNRD) recently shared its financial performance for the third quarter ending September 30, 2024. The company reported a net income of $7.5 million, translating to earnings per diluted share of $1.49. This marks a significant turnaround from the third quarter of 2023, which...

Continue Reading
CytoSorbents Webinar Aims to Combat Sepsis and Septic Shock

Updated Category News Views 129

Understanding the Impact of Sepsis and Septic Shock Sepsis and septic shock pose serious threats in critical healthcare settings. Each year, millions of people are affected by these life-threatening conditions. Recognizing the need for innovative solutions, CytoSorbents Corporation has been at the forefront, utilizing its proprietary blood purification technologies to...

Continue Reading
Summa Defence Plc Updates Shareholding Structure Details

Updated Category News Views 271

Overview of Recent Notifications by Summa Defence Plc Summa Defence Plc has made important announcements relating to their shareholding structure and corporate governance, underscoring the dynamic nature of stockholder engagement. These events reflect the ongoing changes in ownership percentages that can significantly impact their operational strategy. Notification of...

Continue Reading
Quantifind's AI Tech Earns High Marks in Compliance

Updated Category News Views 17

Quantifind among the Industry's Top Innovators Well, here's a name to watch: Quantifind. Recognized as a Top 10 technology provider in financial crime and compliance, this Palo Alto-based firm is making waves. Our friends over at Chartis seem to think highly of them, and they don't toss out accolades willy-nilly. So, what's Quantifind doing that's so special? Pioneering...

Continue Reading
Dolby Laboratories Posts Strong Q1 Results with Promising Growth

Updated Category News Views 164

Strong Start for Dolby Laboratories in FY 2026 Dolby Laboratories, Inc. (NYSE: DLB) recently shared its financial results for the first quarter of fiscal 2026, showcasing promising developments despite the challenging market landscape. The company remains optimistic about its position and future growth opportunities. Kevin Yeaman, President and CEO of Dolby, expressed...

Continue Reading